Novo Integrated Sciences, Inc. (NVOS)
OTCMKTS · Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
Oct 7, 2025, 9:42 AM EDT
Novo Integrated Sciences Market Cap
Novo Integrated Sciences has a market cap or net worth of $9.87 thousand as of October 7, 2025. Its market cap has decreased by -99.92% in one year.
Market Cap
9.87K
Enterprise Value
4.87M
Revenue
13.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 10, 2017, Novo Integrated Sciences's market cap has increased from 8.40K to 9.87K, an increase of 17.44%. That is a compound annual growth rate of 1.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 9.87K | -99.04% |
| Dec 31, 2024 | 1.02M | -92.79% |
| Dec 29, 2023 | 14.20M | 100.45% |
| Dec 30, 2022 | 7.08M | -82.34% |
| Dec 31, 2021 | 40.10M | -59.87% |
| Dec 31, 2020 | 99.93M | -0.88% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |